Skip to main content

MI Classified Into Four Stages Based on Myocardial Tissue Injury

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 6, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 6, 2023 -- In an expert consensus statement published online Oct. 28 in the Canadian Journal of Cardiology, the authors present the classification of four stages of myocardial infarction (MI) based on myocardial tissue injury, culminating in cardiomyocyte and microvascular necrosis.

Andreas Kumar, M.D., from the Northern Ontario School of Medicine University in Sudbury, Canada, and colleagues outlined the Canadian Cardiovascular Society classification of acute MI based on decades of data relating to atherothrombotic MI with reperfusion therapy.

The researchers identified four stages of progressively worsening myocardial tissue injury: aborted MI, with no or minimal myocardial necrosis; MI with significant cardiomyocyte necrosis, with no microvascular injury; microvascular obstruction resulting from cardiomyocyte necrosis and microvascular dysfunction (no-reflow); and cardiomyocyte and microvascular necrosis yielding reperfusion hemorrhage. With progressive injury, worse remodeling and an increase in adverse clinical outcomes were seen in clinical studies. Microvascular injury is of particular importance, with hemorrhagic MI leading to infarct expansion and mechanical complication risk.

"The new classification will help differentiate heart attacks according to the stage of tissue damage and allow health care providers to estimate a patient's risk more precisely for arrhythmia, heart failure, and death," Kumar said in a statement. "The Canadian Cardiovascular Society Classification of Acute Myocardial Infarction is ultimately expected to lead to better care, better recovery, and better survival rates for heart attack patients."

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI

WEDNESDAY, April 10, 2024 -- Empagliflozin does not reduce the risk for first hospitalization for heart failure or death among patients at increased risk for heart failure after...

ACC: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI

MONDAY, April 8, 2024 -- For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a...

Risk for MI, Stroke, Death Increased With Plastics in Carotid Plaques

FRIDAY, March 8, 2024 -- Patients in whom microplastics and nanoplastics (MNPs) are detected within carotid plaques have an increased risk for a composite end point of myocardial...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.